Autophinib is primarily used in scientific research to study autophagy, a cellular process involved in the degradation and recycling of cellular components. It functions as a potent and selective inhibitor of autophagy by targeting key proteins involved in autophagosome formation. Researchers use Autophinib to investigate the role of autophagy in various biological contexts, including cancer, neurodegenerative diseases, and cellular response to stress. By blocking autophagy, it helps in understanding how cancer cells survive under nutrient deprivation and how inhibiting this pathway can enhance the efficacy of other anticancer therapies. Its application is thus confined to laboratory settings, particularly in cell biology and pharmacology studies aiming to develop new therapeutic strategies.